Government Panel Recommends Retaining Doorstep Medicine Delivery Rule with Stricter Enforcement
A government sub-committee has recommended retaining the 2020 rule allowing doorstep delivery of medicines, emphasizing its importance for elderly, chronic patients, and those in rural or remote areas. The All India Organisation of Chemists and Druggists had sought withdrawal, citing misuse by digital platforms like Swiggy and concerns over prescription verification. The sub-committee advised stricter enforcement of existing regulations rather than revoking the notification, following deliberations by the Drugs Technical Advisory Board and a detailed review.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (52/100). Lens Score 55/100.
Outlets measured: economictimes, mint. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–52/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
mint broke this story on 8 Sept, 07:04 am. Other outlets followed.
- 1